|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 69.68 GBX | -4.55% |
|
+1.68% | +20.08% |
| 24/02 | Avacta hails new data supporting proprietary preCision platform | AN |
| 24/02 | Avacta Therapeutics Plans FAP-Exd's Clinical Trials After 'Favorable' Experimental Analysis | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Equities
- AVCT Stock
- Charts Avacta Group Plc
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















